Many people lose significant amounts of subcutaneous fat on GLP-1 medications while their visceral stores remain relatively intact
Promoting the use of such compounds for healing and performance enhancement is unethical and banned by the US Anti-Doping Agency
Why We Picked Them: The clinics published menu is focused rather than sprawling 5 named compounds with clear category positioning
Store in the patients permanent clinical file with treatment date, batch/lot number, and post-injection observations
TB-500 / BPC-157 blend continues to be studied in research settings focused on cellular signaling pathways, peptide interaction frameworks, and multi-compound pathway analysis under controlled laboratory conditions
We have recently demonstrated that selective neuronal stimulation in the contralesional LCN using optogenetic approaches resulted in robust and persistent recovery after stroke, as stroke mice maintained their improved performance even after cessation of stimulation for 2 weeks [75]
